跳到正文
穿戴裝置與測量科學隨機對照試驗3 分鐘閱讀

慢阻肺的手機應用加活動手環:前景可期,但可行性試驗中47%退出

MoveVitals 編輯部 · 研究發表 · 解讀更新

原文:The Use of a Smartphone App and an Activity Tracker to Promote Physical Activity in the Management of Chronic Obstructive Pulmonary Disease: Randomized Controlled Feasibility Study. · JMIR mHealth and uHealth · 2020 · 論文原文 ↗

先看重點

在一項納入30名慢阻肺患者的可行性試驗中,47%(14/30)退出,常見原因是技術難以使用,但留下來的人大多評價正面。該試驗旨在檢驗大型試驗是否可行,而非證明獲益,且完成者健康狀況更好、更熟悉數字技術。

證據類型

隨機對照試驗

解讀依據

公開摘要

閱讀重點

對照與不確定性

研究在問什麼

保持活動對慢性阻塞性肺疾病(慢阻肺)患者有益,但許多人在肺康復結束後活動量下降。研究者檢驗了智慧手機應用加活動追蹤器(SMART-COPD)用於維持活動是否可接受、好用,以及開展正式大型試驗是否可行。

研究對象與方法

隨機可行性研究,30名慢阻肺患者被分入SMART-COPD介入組(n=19)或對照組(n=11)。參與者在整個肺康復期間及之後8週內使用應用和追蹤器設定活動目標並監測進展。分別在基線、肺康復結束和維持期結束時收集問卷和活動結局。研究還訪談了參與者及參與肺康復的醫務人員。

主要發現

以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。

  1. 1
    總體上,47%(14/30)的參與者退出,常見原因是使用技術有困難。
  2. 2
    與退出者相比,完成研究者基線健康狀況更好,之前使用數字技術的經驗也更多。
  3. 3
    完成者總體評價正面,覺得技術容易使用,部分人覺得它對健康和實現活動目標有幫助。
  4. 4
    追蹤器資料和自我報告作為身體活動的評估方式都有問題,部分對照組成員對分組感到不滿。

限制與不確定性

  1. 1
    只有30名參與者且近半退出,所報告的體驗來自一個自我篩選的、更健康也更熟悉技術的群體。
  2. 2
    可行性試驗並非為估計療效而設計,摘要也未報告活動量或健康方面的效應估計。
  3. 3
    活動追蹤器和自我報告都不適合作為結局指標,這限制了此類試驗能證明的內容。
  4. 4
    本解讀僅基於摘要。

日常健康啟示

這提示對慢阻肺患者來說,應用加追蹤器的支援對不少人可以接受,但對所有人還不夠簡單,可能更適合熟悉技術、病程較早的人。這並不能證明該方案可提高活動量。關於慢阻肺的運動問題,應向主治醫師或康復團隊諮詢。

如何連結自己的資料

本研究中追蹤器的步數很難作為可靠的結局指標,這提醒你:同一裝置戴在同一手腕,比較自己每週平均步數的變化,而不是看單日資料。如果裝置或應用成了負擔,堅持得下去的簡單記錄比複雜設定更好。

如何理解這類證據

隨機分組有助於因果推斷,仍須檢查分配、盲法、失去追蹤、追蹤時間和具體對照;標為隨機試驗不自動意味著高確定性。

作者的結構化摘要 English

以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。

Background

Chronic obstructive pulmonary disease (COPD) is highly prevalent and significantly affects the daily functioning of patients. Self-management strategies, including increasing physical activity, can help people with COPD have better health and a better quality of life. Digital mobile health (mHealth) techniques have the potential to aid the delivery of self-management interventions for COPD. We developed an mHealth intervention (Self-Management supported by Assistive, Rehabilitative, and Telehealth technologies-COPD [SMART-COPD]), delivered via a smartphone app and an activity tracker, to help people with COPD maintain (or increase) physical activity after undertaking pulmonary rehabilitation (PR).

Objective

This study aimed to determine the feasibility and acceptability of using the SMART-COPD intervention for the self-management of physical activity and to explore the feasibility of conducting a future randomized controlled trial (RCT) to investigate its effectiveness.

Methods

We conducted a randomized feasibility study. A total of 30 participants with COPD were randomly allocated to receive the SMART-COPD intervention (n=19) or control (n=11). Participants used SMART-COPD throughout PR and for 8 weeks afterward (ie, maintenance) to set physical activity goals and monitor their progress. Questionnaire-based and physical activity-based outcome measures were taken at baseline, the end of PR, and the end of maintenance. Participants, and health care professionals involved in PR delivery, were interviewed about their experiences with the technology.

Results

Overall, 47% (14/30) of participants withdrew from the study. Difficulty in using the technology was a common reason for withdrawal. Participants who completed the study had better baseline health and more prior experience with digital technology, compared with participants who withdrew. Participants who completed the study were generally positive about the technology and found it easy to use. Some participants felt their health had benefitted from using the technology and that it assisted them in achieving physical activity goals. Activity tracking and self-reporting were both found to be problematic as outcome measures of physical activity for this study. There was dissatisfaction among some control group members regarding their allocation.

Conclusions

mHealth shows promise in helping people with COPD self-manage their physical activity levels. mHealth interventions for COPD self-management may be more acceptable to people with prior experience of using digital technology and may be more beneficial if used at an earlier stage of COPD. Simplicity and usability were more important for engagement with the SMART-COPD intervention than personalization; therefore, the intervention should be simplified for future use. Future evaluation will require consideration of individual factors and their effect on mHealth efficacy and use; within-subject comparison of step count values; and an opportunity for control group participants to use the intervention if an RCT were to be carried out. Sample size calculations for a future evaluation would need to consider the high dropout rates.

來源與署名

The Use of a Smartphone App and an Activity Tracker to Promote Physical Activity in the Management of Chronic Obstructive Pulmonary Disease: Randomized Controlled Feasibility Study.

Bentley CL, Powell L, Potter S, Parker J, Mountain GA, Bartlett YK, Farwer J, O'Connor C, Burns J, Cresswell RL, Dunn HD, Hawley MS.

JMIR mHealth and uHealth · 2020-06-03

DOI: 10.2196/16203 ↗PubMed · 32490838 ↗Europe PMC · 所記錄的開放授權: cc by ↗

摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。

MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱

來源查核日期 2026-11-01

實用健康指南

放在一起讀

·世代研究

加速度計處理方法不同,身體活動與中風、心肌梗死的關聯曲線也不同

在英國生物銀行中,基線無心血管疾病的90237名成年人追蹤至2022年12月,共發生1298例中風和2031例心肌梗死;中高強度身體活動(MVPA)與這兩種結局的關聯曲線形狀,取決於加速度計資料的處理方法。就中風而言,只有機器學習法得到直線下降的風險;就心肌梗死而言,機器學習法和LFENMO法呈曲線下降,活動計數法呈直線下降。摘要沒有給出風險比,只能說明不同方法的結論不一致,不能說明哪種方法更正確,而且這些只是觀察性關聯。

Preventive Medicine

重點論文精講閱讀論文 →
·測量驗證研究/回顧

智慧手錶資料能當「證人」嗎:心率驗證得最充分,其餘證據參差

一項圍繞數字取證展開的系統評價和統合分析,梳理了四大主流品牌智慧手錶的驗證研究,發現心率是研究最多、也最準確的指標。步數、距離、能量消耗、活動分類和睡眠的驗證不夠一致,結果因品牌、方案和報告方式而異。摘要沒有給出彙總資料,且多數研究是在健康族群中、於實驗室內完成的,所以無法說明某一塊手錶對某個人在日常生活中的表現。

Forensic Science International

重點論文精講閱讀論文 →
·回顧的回顧

活動追蹤器:每天多走約1800步,對其他健康指標影響較小

這項傘形綜述彙總了39篇系統評價和統合分析,涉及163992名參與者;結果顯示使用活動追蹤器與身體活動增加相關(標準化均數差SMD為0.3–0.6),相當於每天多走約1800步、多步行40分鐘,體重減輕約1公斤。對血壓、膽固醇、糖化血紅蛋白、生活質量和疼痛的影響通常很小,且多數不顯著。摘要沒有說明這些專案裡追蹤器還搭配了什麼,也沒有說明各評價之間重疊多少,因此不能把效果完全歸功於裝置本身。

The Lancet Digital Health

重點論文精講閱讀論文 →
·測量驗證研究/回顧

七款睡眠追蹤裝置:識別睡著很準,識別醒著和睡眠分期較差

在睡眠實驗室裡,34名健康的年輕成年人連續三晚佩戴七款消費級睡眠追蹤裝置中的若干款。與多導睡眠監測相比,所有裝置識別睡眠都很準(靈敏度均不低於0.93),但識別清醒較差(特異度0.18–0.54),七款中有五款與研究用活動記錄儀(特異度0.39)持平或更好;睡眠分期的估計結果不穩定。受試者是18至35歲的健康成年人,臥床時間固定為8小時,每款裝置只在其中11至20人身上測試,因此對有睡眠問題的人幾乎沒有參考價值。

Sleep

重點論文精講閱讀論文 →
穿戴裝置與測量科學 →